JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Simulations Plus Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

17.15 -2.5

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

17.15

Max

18.24

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-70M

-67M

Pardavimai

-2.1M

20M

P/E

Sektoriaus vid.

48.528

37.461

Dividendų pajamingumas

0.48

Pelno marža

-330.585

Darbuotojai

243

EBITDA

-79M

-74M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-9.19% downside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.48%

2.33%

Kitas uždarbis

2025-10-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-28M

323M

Ankstesnė atidarymo kaina

19.65

Ankstesnė uždarymo kaina

17.15

Naujienos nuotaikos

By Acuity

38%

62%

133 / 371 reitingas Healthcare

Simulations Plus Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-22 22:47; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

2025-10-22 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

2025-10-22 21:20; UTC

Uždarbis

Correction to IBM 3Q Sales Jump Article

2025-10-22 20:57; UTC

Uždarbis

SAP Posts Higher 3Q Revenue, Operating Profit

2025-10-22 23:46; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-22 23:46; UTC

Rinkos pokalbiai

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

2025-10-22 23:41; UTC

Rinkos pokalbiai

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

2025-10-22 23:38; UTC

Rinkos pokalbiai

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

2025-10-22 23:15; UTC

Uždarbis

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

2025-10-22 22:28; UTC

Rinkos pokalbiai

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

2025-10-22 22:02; UTC

Uždarbis

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

2025-10-22 21:59; UTC

Įsigijimai, susijungimai, perėmimai

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

2025-10-22 21:58; UTC

Įsigijimai, susijungimai, perėmimai

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

2025-10-22 21:57; UTC

Įsigijimai, susijungimai, perėmimai

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

2025-10-22 21:56; UTC

Įsigijimai, susijungimai, perėmimai

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

2025-10-22 21:47; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

2025-10-22 21:47; UTC

Uždarbis

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

2025-10-22 21:47; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

2025-10-22 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

2025-10-22 21:45; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

2025-10-22 21:45; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

2025-10-22 21:28; UTC

Rinkos pokalbiai
Uždarbis

Correction to Alcoa Tariff Market Talk

2025-10-22 21:25; UTC

Uždarbis

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

2025-10-22 21:17; UTC

Uždarbis

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

2025-10-22 21:09; UTC

Rinkos pokalbiai
Uždarbis

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

2025-10-22 21:00; UTC

Rinkos pokalbiai

ESG Roundup: Market Talk

2025-10-22 20:59; UTC

Uždarbis

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

2025-10-22 20:51; UTC

Uždarbis

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

2025-10-22 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-22 20:44; UTC

Uždarbis

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Akcijų palyginimas

Kainos pokytis

Simulations Plus Inc Prognozė

Kainos tikslas

By TipRanks

-9.19% į apačią

12 mėnesių prognozė

Vidutinis 16 USD  -9.19%

Aukščiausias 16 USD

Žemiausias 16 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Simulations Plus Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

2

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

133 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat